Results 201 to 210 of about 202,372 (256)

Innovative approaches in the treatment of hematologic malignancies: the role of CRISPR-engineered microbiomes along the gut-immune axis in immunotherapy development. [PDF]

open access: yesCancer Cell Int
Hsu CY   +9 more
europepmc   +1 more source

The Role of Gut Microbiota in Acute Myeloid Leukemia. [PDF]

open access: yesJ Clin Med
Inglezou LM   +9 more
europepmc   +1 more source

Drug repurposing to overcome microbial resistance

Drug Discovery Today, 2022
Infections are a growing global threat, and the number of resistant species of microbial pathogens is alarming. However, the rapid development of cross-resistant or multidrug-resistant strains and the development of so-called 'superbugs' are in stark contrast to the number of newly launched anti-infectives on the market. In this review, I summarize the
Josef JampĂ­lek
exaly   +4 more sources

Microbial and viral drug resistance mechanisms

Trends in Microbiology, 2002
Microorganisms and viruses have developed numerous resistance mechanisms that enable them to evade the effect of antimicrobials and antivirals. As a result, many have become resistant to almost every available means of treatment. This problem, although not new, is becoming increasingly acute and it is now clear that a fundamental understanding of the ...
Adrian R Walmsley
exaly   +3 more sources

Biocides, drug resistance and microbial evolution

Current Opinion in Microbiology, 2001
Antimicrobial biocides are widely used in critical human health situations in which rigorous infection control is needed. Increasingly, biocidal agents are being marketed for home use, although there is little evidence that they significantly improve home hygiene. Biocide resistance mechanisms share many themes with antibiotic resistance mechanisms.
David G White
exaly   +3 more sources

Home - About - Disclaimer - Privacy